Patents by Inventor Muh-Hwan SU

Muh-Hwan SU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for treating or preventing angina or myocardial infarction induced by myocardial ischemia
    Patent number: 9446018
    Abstract: The present invention provides a pharmaceutical composition for the treatment and prophylaxis of angina and myocardial infarction, wherein a combination of a tea extract (catechins) and an antianginal drug are proved therapeutically potent in treating angina and mycocardial infarction induced from myocardial ischemia. The present invention also provides a use of a tea extract (catechins) in treating and preventing angina.
    Type: Grant
    Filed: July 10, 2009
    Date of Patent: September 20, 2016
    Assignee: SINPHAR TIAN-LI PHARMACEUTICAL CO., LTD. (HANGZHOU)
    Inventors: Muh-Hwan Su, Jing Jing Justine Tang, Hang-Ching Lin
  • ISOACTEOSIDE DERIVATIVE AND USE THEREOF
    Publication number: 20150291645
    Abstract: An isoacteoside derivative and forming method and uses thereof are provided. The isoacteoside derivative has the structure of formula (I): in formula (I), R1 and R2 being independently selected from hydrogen, halogen, hydroxy group, or hydrocarboxyl group, R3 and R4 being independently selected from hydroxy group, hydrocarboxyl group, or acyloxy group, and R5 being independently selected from hydroxy group or acyloxy group.
    Type: Application
    Filed: April 10, 2015
    Publication date: October 15, 2015
    Inventors: Muh-Hwan Su, Hang-Ching Lin, Ming-Kuan Hu, Yita Lee, Zhao-Ri Wang
  • PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING AMYLOID BETA PEPTIDE-ASSOCIATED DISEASES OR CONDITIONS
    Publication number: 20150087606
    Abstract: A pharmaceutical composition containing isoacteoside to the acteoside is provided, which is able to inhibit formation, accumulation or aggregation of amyloid ? peptides, and is thus useful in preventing or treating amyloid beta peptide-associated diseases or conditions, wherein a weight ratio of the isoacteoside to the acteoside is 4:1 to 1:4.
    Type: Application
    Filed: December 17, 2012
    Publication date: March 26, 2015
    Inventors: Hang-Ching Lin, Muh-Hwan Su, Young-Ming Huang, Jing-Jing Tang
  • PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING ANGINA OR MYOCARDIAL INFARCTION INDUCED BY MYOCARDIAL ISCHEMIA
    Publication number: 20120232041
    Abstract: The present invention provides a pharmaceutical composition for the treatment and prophylaxis of angina and myocardial infarction, wherein a combination of a tea extract (catechins) and an antianginal drug are proved therapeutically potent in treating angina and mycocardial infarction induced from myocardial ischemia. The present invention also provides a use of a tea extract (catechins) in treating and preventing angina.
    Type: Application
    Filed: July 10, 2009
    Publication date: September 13, 2012
    Applicant: SINPHAR TIAN-LIPHARMACEUTICAL CO., LTD. (HANGZHOU)
    Inventors: Muh-Hwan Su, Jing Jing Justine Tang, Hang-Ching Lin
  • METHOD FOR PREVENTING OR TREATING AMYLOID BETA PEPTIDE-ASSOCIATED DISEASES OR CONDITIONS, AND METHOD FOR INHIBITING FORMATION, ACCUMULATION OR AGGREGATION OF AMYLOID BETA PEPTIDES
    Publication number: 20120009131
    Abstract: Isoacteoside or a pharmaceutically acceptable salt thereof is used to prevent or treat amyloid beta peptide-associated diseases or conditions as an agent for inhibiting formation, accumulation or aggregation of amyloid beta peptides.
    Type: Application
    Filed: June 15, 2011
    Publication date: January 12, 2012
    Applicant: Sinphar Tian-Li Pharmaceutical Co., Ltd. (Hangzhou)
    Inventors: Hang-Ching LIN, Jing Jing Justine TANG, Muh-Hwan SU, Young-Ming HUANG